Injectable PrEP

• The FDA approved Apretude (cabotegravir) for use in at-risk adults and adolescents weighing at least 77 pounds to reduce the risk of sexually acquired HIV.

• Apretude is first given as two injections one month apart, and then every two months thereafter. Patients can either start their treatment with Apretude or take oral cabotegravir (Vocabria) for four weeks to see how well they tolerate the drug.

• Apretude cannot be started on the same day as an appointment, but we can get you started on oral PrEP as our team has to contact your insurance company to confirm coverage (usually a 1-2 week turnaround unless a patient needs a prior authorization which can take a few weeks).

• Lab work is required 1-7 days before starting Apretude to confirm you are HIV-, and is mandatory for every injection appointment.

• If your insurance requires any type of coinsurance, there is a copay card for financial assistance for people with commercial insurance (not applicable to Medicaid or Medicare).

• Apretude gives people another choice - especially those who don't like taking daily pills.